NCT03229200 2025-10-30Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib.Pharmacyclics Switzerland GmbHPhase 4 Active not recruiting297 enrolled
NCT00003398 2019-10-17Bone Marrow Transplantation in Treating Patients With Hematologic CancerUniversity of Maryland, BaltimorePhase 4 Completed45 enrolled